What is Alexso?
Alexso Inc., established in 2010 and headquartered in Los Angeles, California, operates as a privately held pharmaceutical wholesaler. The company has carved out a significant niche by specializing in non-opioid pain management solutions. Alexso provides a diverse portfolio of clinically tested products and services to a broad spectrum of healthcare providers, including hospitals, physicians, retail pharmacies, and other wholesalers. Its strategic focus on pain relief innovation and commitment to excellence has fueled its expansion within specialized markets.
How much funding has Alexso raised?
Alexso has raised a total of $352K across 2 funding rounds:
Debt
$150K
Debt
$202K
Debt (2020): $150K with participation from PPP
Debt (2021): $202K led by PPP
What's next for Alexso?
With its recent major strategic investment and a substantial overall funding base of $352K, Alexso is well-positioned for its next phase of expansion. The company's stated aim to grow internationally, coupled with its established presence in niche markets, suggests a strategic push to broaden its global reach and solidify its partnerships. This capital infusion is expected to accelerate product development, enhance distribution networks, and further its mission of promoting patient well-being through advanced pain management alternatives.
See full Alexso company page
